PerkinElmer, Inc., a global leader focused on the health and safety of people and the environment, today announced the launch of the new EnSight™ Multimode Plate Reader. The EnSight system is the first plate reader on the market to offer both labeled and label-free detection, together with well-imaging technology (which facilitates cell imaging), on a single benchtop system. This unique combination allows researchers to run their assays on the same platform -- generating more predictive results earlier in the drug discovery process.
Scientists can use the EnSight system for their research into cancer, cytotoxicity, biotherapeutics, epigenetics and primary/stem cells. The EnSight system enables researchers to generate more reliable readouts and obtain an expanded set of data from their samples. They can also use the EnSight system’s variety of technology modes to perform confirmatory assays, helping to ensure that results are not biased to the detection technologies used for their sampling.
...
